SciELO - Scientific Electronic Library Online

 
vol.28 issue2Uses of the high-flow nasal cannula for COVID-19 patients. How does it work an what are its indications? Is it safe or patients with acute hypoxic respiratory failure?Heart failure with preserved ejection fraction: overview and perioperative management author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

Related links

  • On index processCited by Google
  • Have no similar articlesSimilars in SciELO
  • On index processSimilars in Google

Share


Revista Med

Print version ISSN 0121-5256On-line version ISSN 1909-7700

Abstract

VASQUEZ-SALAZAR, Ana Camila  and  URIBE-ARDILA, Alfredo. Beta-Glucosidase analysis in collected dried blood spots (DBS), report of a new method applied to the control population and patients with suspicion of Gaucher disease. Rev. Med [online]. 2020, vol.28, n.2, pp.35-48.  Epub June 04, 2021. ISSN 0121-5256.  https://doi.org/10.18359/rmed.4857.

Gaucher disease (GD) is a lysosomal storage disorder characterized by a deficiency in the enzymatic activity of β-glucosidase (BGLU), resulting in the accumulation of glucosylceramide in cells. Its diagnosis is aimed at checking the enzyme in the affected leukocytes. Studies have been conducted on dried blood spots (DBS) for bglu activity to monitor high-risk populations; however, they exhibit interferences related to severe leukopenias or increased expression of the neutral bglu isoform, a molecule not related to gd. This study intends to standardize a screening method on dbs (punch: 5 mm) using 4-methylumbelliferyl-β-D-glucoside and conduritol-β-epoxide (CβE). dbs samples from 395 individuals clinically suspected of gd (high-risk or hr population), 151 controls, and 16 affected patients were analyzed using the elution of 5 mm punches (≈10 μl of blood) in 300 μl of Triton X-100/ (0.5 %). As a result, the following ranges were obtained; HR: 0.84-26.92 nmol/ml/h, controls: 3.56-8.92 nmol/ml/h (M = 5.56, SD = 1.15), and patients with confirmed GD: 0.82-2.88 nmol/ml/h (M = 1.64, SD = 0.57). The cut-off point between patients with gd and controls was 3.22 nmol/ml/h, obtained from roc analysis (99 % ci, 100 % sensitivity, and 100 % specificity). The protocol revealed a deficiency in all gd cases, confirmed by parallel bglu analysis in isolated leukocytes. The use of cbe and the elution of 5 mm punches are recommended for enzymatic evaluation with a higher approximate volume of blood and in the absence of neutral isoform activity.

Keywords : Gaucher disease; β-glucosidase; glucocerebrosidase; dried blood spots.

        · abstract in Spanish | Portuguese     · text in Spanish     · Spanish ( pdf )